ConductScience.org, home

Paper41574478

Tumor-Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs.

Ponnamperumage TNF and 7 others. Chemistry, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Tumor-Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs. Papers, record 41574478. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41574478

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor-Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs.
PubMed
Journal
Chemistry
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ponnamperumage TNFThilini Nimasha Fernando
2Mahendran MMayurika
3Awoyera WOWasiu Olaniyi
4Miller CJCody Joshua
5Ali TTaufeeque
6Hill DEDalton Edmund
7Raschka NHNatalie Hope
8Peng XXiaohuahttps://orcid.org/0000-0001-5627-0606

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProdrugsMajor topic
NeoplasmsMajor topic
MechlorethamineMajor topic
Nitrogen Mustard CompoundsMajor topic
Humans
Reactive Oxygen Species
Hydrogen-Ion Concentration
DNA
Antineoplastic Agents
Animals

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R15 CA277656NCI NIH HHSUnited StatesR15CA277656PubMed
1R15CA277656-01NCI NIH HHSUnited StatesR15CA277656PubMed

Source NIH RePORTER

Download CSV of grants

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117606726Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.Clin Cancer Res2007https://conductscience.org/library/papers/17606726PubMed
28356908Role of glutathione in cellular resistance to alkylating agents.Adv Enzyme Regul1993https://conductscience.org/library/papers/8356908PubMed
339757165Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer.Cell Mol Biol Lett2025https://conductscience.org/library/papers/39757165PubMed
421606941Targeting hypoxia in cancer therapy.Nat Rev Cancer2011https://conductscience.org/library/papers/21606941PubMed
57707327Hypoxia-selective antitumor agents. 11. Chlorambucil N-oxide: a reappraisal of its synthesis, stability, and selective toxicity for hypoxic cells.J Med Chem1995https://conductscience.org/library/papers/7707327PubMed
627992994
A New Cross-Link for an Old Cross-Linking Drug: The Nitrogen Mustard Anticancer Agent Mechlorethamine Generates Cross-Links Derived from Abasic Sites in Addition to the Expected Drug-Bridged Cross-Links.
Biochemistry2016https://conductscience.org/library/papers/27992994PubMed
717440684Hypoxia in cancer: significance and impact on clinical outcome.Cancer Metastasis Rev2007https://conductscience.org/library/papers/17440684PubMed
821833026Dysregulated pH: a perfect storm for cancer progression.Nat Rev Cancer2011https://conductscience.org/library/papers/21833026PubMed
939124883Recent Advances in the Application of Nitro(het)aromatic Compounds for Treating and/or Fluorescent Imaging of Tumor Hypoxia.Molecules2024https://conductscience.org/library/papers/39124883PubMed
1026713684Preparation of Conjugated Polymer Grafted with H2O2-Sensitive Prodrug for Cell Imaging and Tumor Cell Killing.ACS Appl Mater Interfaces2016https://conductscience.org/library/papers/26713684PubMed
1123845143Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia.Chin J Cancer2014https://conductscience.org/library/papers/23845143PubMed
128515422Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.J Med Chem1993https://conductscience.org/library/papers/8515422PubMed
1328140568DNA Adduct Profiles Predict in Vitro Cell Viability after Treatment with the Experimental Anticancer Prodrug PR104A.Chem Res Toxicol2017https://conductscience.org/library/papers/28140568PubMed
148691449Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.J Med Chem1996https://conductscience.org/library/papers/8691449PubMed
1537492477Association between pH regulation of the tumor microenvironment and immunological state.Front Oncol2023https://conductscience.org/library/papers/37492477PubMed
1630199705Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma.Eur J Med Chem2018https://conductscience.org/library/papers/30199705PubMed
1720222798Hypoxia-activated prodrugs in cancer therapy: progress to the clinic.Future Oncol2010https://conductscience.org/library/papers/20222798PubMed
1826911188Antitumour actions of interferons: implications for cancer therapy.Nat Rev Cancer2016https://conductscience.org/library/papers/26911188PubMed
2041550162Targeted drug conjugates in cancer therapy: Challenges and opportunities.Pharm Sci Adv2024https://conductscience.org/library/papers/41550162PubMed
218358728Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.Cancer Res1993https://conductscience.org/library/papers/8358728PubMed

See all 91 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42622024Unraveling the Crosstalk Between Ferroptosis and Cuproptosis for Rational Nanomedicine Design in Cancer.Int J Nanomedicine2026https://conductscience.org/library/papers/42622024

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41574478

GET https://conductscience.org/api/papers/v1/41574478/references?page=2